Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development.
Vogel CFA, Lazennec G, Kado SY, Dahlem C, He Y, Castaneda A, Ishihara Y, Vogeley C, Rossi A, Haarmann-Stemmann T, Jugan J, Mori H, Borowsky AD, La Merrill MA, Sweeney C.
Vogel CFA, et al.
Front Immunol. 2021 Mar 8;12:625346. doi: 10.3389/fimmu.2021.625346. eCollection 2021.
Front Immunol. 2021.
PMID: 33763068
Free PMC article.